The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
Conditions: Falciparum; Malaria Interventions: Drug: Artemether-lumefantrine; Drug: Dihydroartemisinin-Piperaquine Sponsors: Infectious Diseases Research Collaboration, Uganda; London School of Hygiene and Tropical Medicine; Radboud University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic Syndrome
Conditions: Parasitic Disease Interventions: Other: Follow up of multiple sclerotic and nephrotic syndrome patients after 3 months Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Parasitic Ulcer Treatment Trial
Conditions: Acanthamoeba Keratitis Interventions: Drug: Polyhexamethylene biguanide (PHMB); Drug: Topical corticosteroid; Other: Topical placebo Sponsors: Jeremy Keenan, MD, MPH; Johns Hopkins University; Oregon Health and Science University; University of Illinois at Chicago; University of Michigan; University of California, Los Angeles; University of Miami; University of Pennsylvania; Columbia University; University of Iowa; University of Florida; Aravind Eye Care System; Moorfields Eye Hospital NHS Foundation Trust; Federal University of S ão Paulo; National Eye Institute (NEI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Could Wearing Face Mask Have Affected Demodex Parasite
Conditions: Pandemic, COVID-19; Demodex Infestation Interventions: Diagnostic Test: standard superficial skin biopsy (SSSB) Sponsors: Nurhan D öner Aktaş Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Parasite Clearance and Protection From Infection (PCPI) in Cameroon
Conditions: Malaria Interventions: Drug: SP (Macleods Pharmaceuticals Ltd); Drug: SPAQ (Guilin Pharmaceuticals); Drug: AS (Guilin Pharmaceuticals) Sponsors: London School of Hygiene and Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Parasite Clearance and Protection From Infection (PCPI) in Zambia
Conditions: Malaria Interventions: Drug: SP (Macleods Pharmaceuticals Ltd); Drug: AS (Guilin Pharmaceuticals) Sponsors: London School of Hygiene and Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection
This study assesses a strategy for repurposing artemisinin-based combination therapies (ACTs) for treating schistosomiasis. It adopts a head-to-head comparison of four different ACTs to test a non-inferiority hypothesis and to strengthen local capacity to conduct clinical trials for interventions against neglected tropical diseases.Trial registrationPan-African Clinical Trials RegistryPACTR202001919442161. Retrospectively registered on 6 January 2020 (Source: Trials)
Source: Trials - November 27, 2023 Category: Research Source Type: clinical trials
A Study to Compare Two Dosing Regimens for a New Malaria Vaccine
Conditions: Malaria; Malaria,Falciparum; Protozoan Infections; Parasitic Disease; Infections; Vector Borne Diseases Interventions: Biological: Matrix M with RH5.1 Sponsors: University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
Conditions: Sexual Conversion of Plasmodium Falciparum; Single Cell RNA-sequencing (scRNA-seq); Untargeted Metabolomics; Transmission; Immune Factors Sponsors: Institute of Tropical Medicine, Belgium; Instituto Nacional de Sa úde, Mozambique; Clinical Research Unit of Nanoro (CRUN), Burkina Faso; Barcelona Institute for Global Health; Leiden University Medical Center; KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
Pattern of Intestinal Parasitic Infection Among Cirrhotic Patients in Sohag University Hospital
Condition: Liver Cirrhosis Intervention: Diagnostic Test: stool analysis Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2023 Category: Research Source Type: clinical trials
